Drug selection for the treatment of vestibular migraine
- VernacularTitle:前庭性偏头痛治疗药物选择
- Author:
Baihua WU
1
;
Ming DONG
1
;
Jiachun FENG
1
Author Information
- Publication Type:Journal Article
- Keywords: Vestibular migraine; Acute phase treatment; Preventive treatment
- From: Journal of Apoplexy and Nervous Diseases 2023;40(11):1012-1016
- CountryChina
- Language:Chinese
- Abstract: Vestibular migraine （VM） is a type of paroxysmal vertigo with headaches. The condition is very common in clinical practice，but its pathophysiological mechanism is not fully understood. The clinical manifestations of VM vary greatly and are similar to or overlap with peripheral vertigo diseases such as benign paroxysmal positional vertigo （BPPV） and Meniere's disease （MD），and the neurological examinations of VM usually have no special findings. Therefore，there is no objective gold standard for diagnosis，and exclusive diagnoses are required. Due to the lack of high-level evidence-based studies on the treatment of VM，previous reviews may have been at serious risk of bias due to poor study quality and significant heterogeneity. Despite the poor quality of the overall evidence base for VM treatment，we have systematically performed a clinical practicability-oriented evaluation in this review on the evidence for various treatment options for VM. At the same time，we make treatment recommendations based on this evaluation，hoping to help clinicians in treating patients with VM.
- Full text:2024061320082009286Drug selection for the treatment of vestibular migraine.pdf
